Free Trial
NYSEARCA:DPK

Direxion Daily MSCI Developed Markets Bear 3X Shares (DPK) Price, Holdings, & News

$15.78 0.00 (0.00%)
As of 05/12/2023

About Direxion Daily MSCI Developed Markets Bear 3X Shares (NYSEARCA:DPK)

Key Stats

Today's Range
$15.78
$15.78
50-Day Range
$15.78
$15.78
52-Week Range
$9.48
$26.57
Volume
N/A
Average Volume
63,040 shs
Market Capitalization
$5.28 million
Assets Under Management
$5.30 million
Dividend Yield
1.14%
Net Expense Ratio
1.10%
Aggregate Rating
N/A

ETF Overview

Direxion Daily MSCI Developed Markets Bear 3X Shares Expenses

TypeDPKBroad Equity ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.75%0.52%0.56%0.51%0.53%
Other Expenses1.66%0.50%0.56%0.59%0.56%
Total Expense2.41%0.76%0.76%0.74%0.73%
Fee Waiver-1.31%-0.41%-0.66%-0.71%-0.63%
Net Expense1.10%0.62%0.63%0.58%0.60%
Receive DPK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Direxion Daily MSCI Developed Markets Bear 3X Shares and its competitors with MarketBeat's FREE daily newsletter.

DPK ETF News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big Banks have found a way to use a new asset as if it were cash. Not stocks. Not bonds. Not even the U.S. dollar. They now trust this asset more than the traditional financial system itself.
See More Headlines

DPK ETF - Frequently Asked Questions

Direxion Daily MSCI Developed Markets Bear 3X Shares' stock was trading at $15.7756 at the beginning of 2025. Since then, DPK stock has increased by 0.0% and is now trading at $15.7756.

Shares of DPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily MSCI Developed Markets Bear 3X Shares investors own include Coherus Oncology (CHRS), ContraFect (CFRX), CTI BioPharma (CTIC), Evolus (EOLS), Fate Therapeutics (FATE), Galectin Therapeutics (GALT) and Johnson & Johnson (JNJ).

Fund Details

Issuer
Direxion
Fund Name
Direxion Daily Developed Markets Bear 3X Shares
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:DPK
Inception Date
12/16/2008
Fund Manager
Paul Brigandi, Tony Ng
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
MSCI EAFE Index
Category
Broad Equity
Focus
Broad Equity
Development Level
Developed Markets
Region
Developed Markets
Number of Holdings
0

Fund Statistics

Assets Under Management
$5.30 million
Average Daily Volume
$107.73 thousand
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
U.S. Bancorp Fund Services, LLC
Advisor
Rafferty Asset Management, LLC
Custodian
The Bank of New York Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Virtu Financial

Miscellaneous

Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSEARCA:DPK) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners